Quick Answer
NEUROCRINE BIOSCIENCES INC reported Operating Income of $619.10 million for fiscal year 2025.
NEUROCRINE BIOSCIENCES INC Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | $619.10M | +8.5% |
| 2024 | $570.50M | +127.4% |
| 2023 | $250.90M | +0.8% |
| 2022 | $249.00M | +142.9% |
| 2021 | $102.50M | -37.1% |
| 2020 | $163.00M | +125.4% |
| 2019 | $72.30M | +96.5% |
| 2018 | $36.80M | +128.0% |
| 2017 | -$131.36M | +10.9% |
| 2016 | -$147.37M | -56.4% |
| 2015 | -$94.20M | -46.3% |
| 2014 | -$64.41M | -29.7% |
| 2013 | -$49.68M | -3530.8% |
| 2012 | $1.45M | -95.7% |
| 2011 | $33.92M | +347.2% |
| 2010 | -$13.72M | +74.4% |
| 2009 | -$53.67M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $239.00M | +30.0% | +64.1% |
| June 30, 2025 | $145.60M | +0.1% | +516.9% |
| March 31, 2025 | $23.60M | -76.2% | -87.2% |
| September 30, 2024 | $183.80M | +30.2% | +26.4% |
| June 30, 2024 | $145.40M | +97.6% | +46.4% |
| March 31, 2024 | $99.30M | +187.0% | -29.7% |
| September 30, 2023 | $141.20M | +60.8% | +91.8% |
| June 30, 2023 | $73.60M | +34.6% | +164.4% |
- NEUROCRINE BIOSCIENCES INC showed an increase of +8.5% in Operating Income compared to the prior fiscal year.
- Over the 2009–2025 period, NEUROCRINE BIOSCIENCES INC’s operating income has grown by 1253.5% (from -$53.67 million to $619.10 million).
- The most recent figure is from NEUROCRINE BIOSCIENCES INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 11, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: